Literature DB >> 11079717

Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system.

A Kulkarni-Narla1, D R Brown.   

Abstract

Cannabis has been used for centuries in the medicinal treatment of gastrointestinal disorders. Endogenous cannabinimimetic substances such as 2-arachidonylglycerol have been isolated from gut homogenates and CB1-cannabinoid binding sites have been identified in small intestine. In this study, CB1-cannabinoid receptors (CB1-R) were immunohistochemically localized within the enteric nervous system of the pig, an omnivorous species whose digestive tract is functionally similar to humans. Two anti-CB1-R antisera, raised against N-terminal epitopes in the human CB1-R, were employed to localize receptor immunoreactivity by secondary immunofluorescence. CB1-R immunoreactivity was observed in the myenteric and submucosal ganglionated plexuses of porcine ileum and colon. In the ileum, all CB1-R-immunoreactive neurons coexpressed immunoreactivity to the cholinergic marker, choline acetyltransferase (ChAT). CB1-R/ChAT-immunoreactive neurons appeared to be in close apposition to ileal Peyer's patches, submucosal blood vessels, and intestinal crypts. In the distal colon, CB1-R-immunoreactive neurons also expressed immunoreactivity to ChAT, albeit less frequently than in ileum. Immunoreactivity to vasoactive intestinal peptide or nitric oxide synthase was not colocalized in ileal or colonic CB1-R-immunoreactive neurons. These studies indicate that CB1-R are present in cholinergic neurons in the porcine enteric nervous system. The potential roles of these receptors in intestinal motility and epithelial transport, host defense and visceral pain transmission are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079717     DOI: 10.1007/s004410000261

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  32 in total

Review 1.  Treating irritable bowel syndrome: overview, perspective and future therapies.

Authors:  Michael Camilleri
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

Review 2.  Involvement of cannabinoid receptors in gut motility and visceral perception.

Authors:  Pamela J Hornby; Stephen M Prouty
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

3.  Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.

Authors:  Giorgia Galiazzo; Fiorella Giancola; Agnese Stanzani; Federico Fracassi; Chiara Bernardini; Monica Forni; Marco Pietra; Roberto Chiocchetti
Journal:  Histochem Cell Biol       Date:  2018-06-07       Impact factor: 4.304

4.  Modulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis.

Authors:  Patricia E Molina; Angela M Amedee; Nicole J LeCapitaine; Jovanny Zabaleta; Mahesh Mohan; Peter J Winsauer; Curtis Vande Stouwe; Robin R McGoey; Matthew W Auten; Lynn LaMotte; Lawrance C Chandra; Leslie L Birke
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-07       Impact factor: 2.205

Review 5.  Complementary Therapies in Inflammatory Bowel Diseases.

Authors:  Henit Yanai; Nir Salomon; Adi Lahat
Journal:  Curr Gastroenterol Rep       Date:  2016-12

Review 6.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

7.  The endogenous cannabinoid system protects against colonic inflammation.

Authors:  Federico Massa; Giovanni Marsicano; Heike Hermann; Astrid Cannich; Krisztina Monory; Benjamin F Cravatt; Gian-Luca Ferri; Andrei Sibaev; Martin Storr; Beat Lutz
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 8.  Cannabinoids and GI Disorders: Endogenous and Exogenous.

Authors:  Zachary Wilmer Reichenbach; Ron Schey
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

9.  Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa.

Authors:  María Ruth Pazos; Rosa María Tolón; Cristina Benito; Conrado Fernández Rodríguez; Juan José Gorgojo; Manuel Nevado; Mariano Alvarez; Francisco Arias; Francisca Almodóvar; María Teresa Pérez Fernández; José Luis Lledó; Sara González; José Javier Fernández-Ruiz; Julián Romero
Journal:  J Histochem Cytochem       Date:  2008-02-18       Impact factor: 2.479

10.  Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data.

Authors:  Gabriella Coruzzi; Maristella Adami; Elena Guaita; Alessandro Menozzi; Simone Bertini; Elena Giovannini; Giulio Soldani
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.